Buprenorphine IVD, kit, enzyme immunoassay (EIA)

Buprenorphine IVD kits using enzyme immunoassay (EIA) are laboratory diagnostic tools designed to detect the presence of buprenorphine in clinical specimens, such as urine or blood. Clinicians rely on these tests to confirm buprenorphine use, monitor compliance in addiction treatment programs, or investigate potential drug exposure in medical or forensic settings.

These kits are typically regulated as in vitro diagnostics (IVDs) and may require compliance with standards like ISO 13485 or FDA 21 CFR Part 820, depending on the jurisdiction. They are usually sold as pre-packaged reagent kits, requiring minimal additional equipment for use in accredited laboratories or certified testing facilities.